KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Hologic (HOLX) Asset Writedowns and Impairment (2016 - 2025)

Hologic's Asset Writedowns and Impairment history spans 11 years, with the latest figure at $5.0 million for Q3 2025.

  • For Q3 2025, Asset Writedowns and Impairment changed N/A year-over-year to $5.0 million; the TTM value through Sep 2025 reached $225.9 million, up 913.0%, while the annual FY2025 figure was $225.9 million, 404.24% up from the prior year.
  • Asset Writedowns and Impairment for Q3 2025 was $5.0 million at Hologic, down from $220.9 million in the prior quarter.
  • Across five years, Asset Writedowns and Impairment topped out at $220.9 million in Q1 2025 and bottomed at $4.3 million in Q4 2023.
  • The 4-year median for Asset Writedowns and Impairment is $24.8 million (2022), against an average of $65.3 million.
  • The largest annual shift saw Asset Writedowns and Impairment crashed 92.67% in 2024 before it soared 5037.21% in 2025.
  • A 4-year view of Asset Writedowns and Impairment shows it stood at $35.9 million in 2022, then tumbled by 88.02% to $4.3 million in 2023, then soared by 218.6% to $13.7 million in 2024, then tumbled by 63.5% to $5.0 million in 2025.
  • Per Business Quant, the three most recent readings for HOLX's Asset Writedowns and Impairment are $5.0 million (Q3 2025), $220.9 million (Q1 2025), and $13.7 million (Q2 2024).